EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society

Jean-Claude Deharo, Julien Dreyfus, Maria-Grazia Bongiorni, Haran Burri, Pascal Defaye, Michael Glikson, Nigel Lever, Antonio Mangieri, Blandine Mondésert, Jens Cosedis Nielsen, Maully Shah, Christoph Thomas Starck und 4 weitere

EuroIntervention · 2025-11 · 21 (22) · 1317-1337

DOI: 10.4244/eij-jaa-202501 ↗

Kurz gefasst

Leitlinie in der Zeitschrift EuroIntervention, 2025-11. Verfasst von Jean-Claude Deharo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique - Hôpitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie, 264 Rue Saint-Pierre, 13005 Marseill…. Hauptthemen laut MEDLINE: Cardiac Catheterization, Defibrillators, Implantable, Heart Valve Prosthesis Implantation, Pacemaker, Artificial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Up to one-third of patients referred for transcatheter tricuspid valve intervention (TTVI) have a transvalvular pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead in place. Both the electrophysiology and interventional cardiology communities have been alerted to the complexity of decision-making in this situation due to potential interactions between the leads and the TTVI material, including the risk of jailing or damage to the leads. This document, commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, reviews the scientific evidence to inform Heart Team discussions on the management of patients with a PPM or ICD who are scheduled for or have undergone TTVI. Graphical abstract .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationDefibrillators, ImplantableHeart Valve Prosthesis ImplantationPacemaker, ArtificialTricuspid ValveHumans

Autor:innen und Institutionen

  • Assistance Publique - Hôpitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie, 264 Rue Saint-Pierre, 13005 Marseille, France.
  • Aix Marseille Université, C2VN, 13005 Marseille, France, Bd Jean Moulin, 13005 Marseille, France.
  • Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.
  • Heart Rhythm Clinic, San Rossore Hospital, Pisa, Italy.
  • Cardiac Pacing Unit, Cardiology Departement, University Hospital of Geneva, Geneva, Switzerland.
  • Cardiology Department, Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000 Grenoble, France.

Zitieren

APA

Deharo, J. C., Dreyfus, J., Bongiorni, M. G., Burri, H., Defaye, P., Glikson, M., Lever, N., Mangieri, A., Mondésert, B., Nielsen, J. C., Shah, M., Starck, C. T., Rao, A., Leclercq, C., Praz, F., & Reviewers (2025). Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society. EuroIntervention, 21(22), 1317-1337. https://doi.org/10.4244/eij-jaa-202501

Vancouver

Deharo JC, Dreyfus J, Bongiorni MG, Burri H, Defaye P, Glikson M, et al. Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society. EuroIntervention. 2025;21(22):1317-1337. doi:10.4244/eij-jaa-202501

BibTeX
@article{Deharo2025,
  author = {Deharo, Jean-Claude and Dreyfus, Julien and Bongiorni, Maria-Grazia and Burri, Haran and Defaye, Pascal and Glikson, Michael and Lever, Nigel and Mangieri, Antonio and Mondésert, Blandine and Nielsen, Jens Cosedis and Shah, Maully and Starck, Christoph Thomas and Rao, Archana and Leclercq, Christophe and Praz, Fabien and Reviewers, Reviewers},
  title = {Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society},
  journal = {EuroIntervention},
  year = {2025},
  volume = {21},
  number = {22},
  pages = {1317--1337},
  doi = {10.4244/eij-jaa-202501}
}
Kostenlos starten →